Status:

COMPLETED

How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women

Lead Sponsor:

Stanford University

Conditions:

Postoperative Nausea

Eligibility:

FEMALE

18-45 years

Phase:

PHASE1

PHASE2

Brief Summary

This is called "Aim 1" of the investigators' NIH grant. Ondansetron (Zofran) is a safe and effective drug used in pregnant women to prevent nausea but the investigators do not know what effect pregnan...

Detailed Description

This phase of the study is Aim 1 and it will lead to Aim 2, which specifically will address the Prevention of Neonatal Abstinence Syndrome (NAS). NAS is a constellation of narcotic drug withdrawal sy...

Eligibility Criteria

Inclusion

  • For Non-pregnant Females (Group #1)
  • Age 18-45 yrs inclusive
  • Generally healthy
  • Undergoing any scheduled surgical procedure deemed suitable by the Investigator MD
  • Planned to receive the drug Ondansetron for the surgery
  • Able and willing to sign the informed consent
  • For Pregnant Females (Group #2)
  • Age 18-45 yrs inclusive
  • Term pregnancy (37 weeks through 41 wks + 6 days)
  • Generally healthy (not morbidly obese)
  • Undergoing a planned C-section or by an unplanned, non-urgent C-section
  • Planned to receive the drug Ondansetron for the surgery
  • Single birth
  • Able and willing to sign the informed consent for herself \& the baby
  • For the Neonatal Participant (Group #3)
  • Male or female
  • Viable birth
  • Gestational age of 37 weeks through 41 weeks + 6 days
  • Mother gave written consent for baby to participate

Exclusion

  • Medical condition that would effect the metabolism of ondansetron
  • Known allergy to ondansetron
  • Use of medications in the last 48 hours, by the pregnant or non-pregnant subjects, that might induce or inhibit the metabolism of ondansetron (such as CYP3A4 inhibitors or inducers)

Key Trial Info

Start Date :

January 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01801475

Start Date

January 1 2013

End Date

May 1 2013

Last Update

June 1 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lucile Packard Children's Hospital & Stanford Hospital

Palo Alto, California, United States, 94305

How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women | DecenTrialz